BCL2 Expression Is a Prognostic Marker for the Activated B-Cell-Like Type of Diffuse Large B-Cell Lymphoma.
Carlos Chiattone(Faculdade de Ciências Médicas da Santa Casa de São Paulo), Fernando Augusto Soares(AC Camargo Hospital)
Cited by 39
Related Papers
Prognostic Implications of Altered Human Epidermal Growth Factor Receptors (HERs) in Gastric Carcinomas: HER2 and HER3 Are Predictors of Poor Outcome
|Journal of Clinical Oncology|2011|256